AVEO Oncology Announces Complete Response Letter Received for Tivozanib New Drug Application in Renal Cell Carcinoma
Call ended at 11 Jun 2013 08:41 AMAVEO Oncology Conference Call to Discuss Strategic Restructuring
Call ended at 05 Jun 2013 09:07 AM
Act. -0.49 Est. -0.77
Q4 2012 Aveo Pharmaceuticals In Earnings Conference Call
Call ended at 13 Feb 2013 11:11 AM
Act. -0.69 Est. -0.87
Q3 2012 AVEO Oncology Earnings Conference Call
Call ended at 30 Oct 2012 10:35 AMAVEO Pharmaceuticals, Inc. at Deutsche Bank AG Health Care Conference
Call ended at 08 May 2012 03:45 PM
Act. -0.77 Est. -0.76
Q1 2012 AVEO Pharmaceuticals, Inc. Earnings Conference Call
Call ended at 03 May 2012 10:44 AMAVEO Pharmaceuticals, Inc. at Leerink Swann Global Healthcare Conference
Call ended at 15 Feb 2012 03:30 PM
Act. 0.74 Est. -0.61
Q4 2011 AVEO Pharmaceuticals, Inc. Earnings Conference Call
Call ended at 14 Feb 2012 10:43 AMAVEO and Astellas Announce Tivozanib Successfully Demonstrated Progression-Free Survival Superiority - Conference Call
Call ended at 03 Jan 2012 09:12 AM
Est. -0.55
Q3 2011 Aveo Pharmaceuticals Inc Earnings Conference Call
Call ended at 02 Nov 2011 10:43 AM
Act. 0.16 Est. 0.75
Q2 2011 Aveo Pharmaceuticals Inc Earnings Conference Call
Call ended at 28 Jul 2011 10:39 AM
Previous
No events
Upcoming calls
Page 1 of 1
Showing 0 – 0 of 0 calls
Download
Embed
Share
